Publications by authors named "Fenggui Wei"

Background: Previous studies have investigated the prognostic role of programmed death ligand 1 (PD-L1) expression in patients with neuroblastoma, while the results are still controversial. Therefore, we conducted a meta-analysis to clarify the relationship between the expression of PD-L1 and the prognosis of neuroblastoma.

Methods: Search electronic databases include PubMed, Cochrane, Embase, Scopus and Web of Science, and the search time is set to build the database until January 2021.

View Article and Find Full Text PDF
Article Synopsis
  • FLT3 mutations are linked to poor outcomes in acute myeloid leukemia (AML), and while FLT3 inhibitors can induce remission, resistance often develops in patients over time.
  • 4-Hydroxyphenyl retinamide (4-HPR) has shown promise as a cancer treatment and is particularly toxic to AML cells with FLT3-ITD mutations, suggesting it could be an effective option for these patients.
  • The study found that 4-HPR works by increasing reactive oxygen species (ROS) production and inhibiting NF-κB, which helps target FLT3-mutated AML cells specifically.
View Article and Find Full Text PDF

Purpose: Inherent and/or acquired multi-drug resistance might be the instigator of treatment failure for acute myeloid leukemia (AML). In the current study, we aimed to explored the chemosensitizing effect of 4-HPR on AML therapy.

Methods: Luciferase reporter assays were used to test the effect of 4-HPR on transcriptional signaling pathways.

View Article and Find Full Text PDF

The purpose of this study was to establish the phospho-specific flow cytometry (phospho-flow) to detect the phosphorylated signaling proteins of leukemia cells and to evaluate its useful value in leukemia study. The bone marrow of leukemia children was collected, and treated by phospho-flow of extracted mononuclear cells (MNC) and phospho-flow of directly fixed bone marrow (BM) respectively. In phospho-flow of extracted MNC, the MNC extracted from BM were fixed and permeabilized, then were cultured with P-AKT and P-ERK1/2, finally were analyzed by flow cytometry.

View Article and Find Full Text PDF

The aim of study was to investigate the effect of acute lymphoblastic leukemia (ALL) children bone marrow mesenchymal stem cells (MSC) on resistance of K562/A02 cells and its mechanism. MSC obtained from bone marrow of AL children were cultured and identified. The co-culture of MSC and K562/A02 and the culture of K562/A02 cell suspension alone was performed, of which 2 kinds of cells were treated with same concentration of adriamycin (ADM), and the rate of apoptosis was detected by flow cytometry, bcl-2 and bax of K562/A02 were detected by RT-PCR, while mdr1 gene level was detected by FQ-PCR.

View Article and Find Full Text PDF

This study was purposed to investigate the changes of CD4(+) CD25(+) regulatory T cells and NK cells in peripheral blood of acute leukemia children at different stages, the function of immune system and the possible roles of the CD4(+) CD25(+) regulatory T cells as well as NK cells in leukemia immunity. The number and proportion of CD4(+) CD25(+) regulatory T cells and NK cells were detected by flow cytometry in the peripheral blood of 53 acute leukemia children, including 25 patients in new diagnosis and 28 patients in continuous complete remission (CCR), and were compared with that of 20 normal children. The results indicated that the mean proportion of CD4(+) CD25(+) CD127(+) in CD4(+) T cells of peripheral blood in newly diagnosed patients, patients with CCR and normal children were (9.

View Article and Find Full Text PDF

Objective: To investigate the safety and therapeutic effect of low dose (1000 U/m(2)) L-asparaginase (L-Asp) in the treatment of children with acute lymphoblastic leukemia (ALL).

Methods: Six patients were treated with low dose L-Asp after previously suffered severe side effects from standard dose L-Asp (5000 - 10,000 U/m(2)). Twenty-eight blood samples were obtained randomly from 5 of them.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore the effectiveness of E. coli asparaginase (L-asp) in reducing asparagines (ASN) levels in children with acute lymphoblastic leukemia (ALL) during chemotherapy.
  • Data were collected from 15 children receiving a specific regimen of L-asp, showing that plasma L-asp activity increased after multiple doses while ASN levels significantly decreased.
  • The findings suggest that the current treatment protocol effectively maintains low ASN levels, which is beneficial for treating ALL in children.
View Article and Find Full Text PDF